|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.19 EGP | 0.00% |
|
0.00% | +35.27% |
The Arab Drug Company reported earnings results for the half year ended December 31, 2021. For the half year, the company reported revenue was EGP 280.57 million compared to EGP 291.22 million a year ago. Net income was EGP 49.47 million compared to EGP 58.31 million a year ago.
Basic earnings per share from continuing operations was EGP 7.34 compared to EGP 8.63 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +35.27% | 11.8M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
THE ARAB DRUG COMPANY 
